PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.82%
Revenue growth at 75-90% of CSIQ's 24.34%. Bill Ackman would push for innovation or market expansion to catch up.
-14.41%
Negative gross profit growth while CSIQ is at 31.78%. Joel Greenblatt would examine cost competitiveness or demand decline.
154.68%
EBIT growth above 1.5x CSIQ's 79.48%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
-285.20%
Negative operating income growth while CSIQ is at 26.99%. Joel Greenblatt would press for urgent turnaround measures.
123.94%
Positive net income growth while CSIQ is negative. John Neff might see a big relative performance advantage.
124.49%
Positive EPS growth while CSIQ is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
124.49%
Positive diluted EPS growth while CSIQ is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.08%
Share reduction more than 1.5x CSIQ's 1.08%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.69%
Diluted share count expanding well above CSIQ's 0.93%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
89.83%
OCF growth of 89.83% while CSIQ is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
53.97%
FCF growth of 53.97% while CSIQ is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-61.45%
Negative 10Y revenue/share CAGR while CSIQ stands at 119.26%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-69.98%
Negative 5Y CAGR while CSIQ stands at 108.30%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-31.34%
Negative 3Y CAGR while CSIQ stands at 58.14%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-101.02%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.40%
Negative 5Y OCF/share CAGR while CSIQ is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
92.53%
3Y OCF/share CAGR of 92.53% while CSIQ is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
113.73%
Net income/share CAGR at 75-90% of CSIQ's 129.48%. Bill Ackman would press for strategic moves to boost long-term earnings.
105.87%
Below 50% of CSIQ's 277.43%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
110.42%
Positive short-term CAGR while CSIQ is negative. John Neff would see a clear advantage in near-term profit trajectory.
-82.79%
Negative equity/share CAGR over 10 years while CSIQ stands at 162.83%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-69.16%
Negative 5Y equity/share growth while CSIQ is at 85.42%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
251.81%
3Y equity/share CAGR above 1.5x CSIQ's 36.99%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-29.28%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-11.18%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
8.82%
Positive asset growth while CSIQ is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.19%
BV/share growth above 1.5x CSIQ's 3.45%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
1.24%
Debt shrinking faster vs. CSIQ's 6.91%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
46.53%
R&D growth drastically higher vs. CSIQ's 43.08%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
49.72%
SG&A growth well above CSIQ's 18.59%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.